Calcium channel (includes specific types such as "Calcium ATPase", "Sodium/calcium exchanger", "IP3 receptor", "Ryanodine receptor", etc., depending on context) (Some forms have accepted abbreviations depending on subtype (e.g., VGCC for Voltage-Gated Calcium Channel, SERCA for Sarco/Endoplasmic Reticulum Calcium ATPase, NCX for Sodium-Calcium Exchanger))

Calcium ion transport across biological membranes is a fundamental cellular process mediated by a variety of proteins, including voltage-gated calcium channels, ligand-gated channels (such as IP3 and ryanodine receptors), ATP-dependent pumps (Ca2+-ATPases), and exchangers (sodium/calcium exchangers). These transport mechanisms are critical for regulating intracellular and extracellular calcium levels, which in turn control a wide array of biological functions: from muscle contraction and neurotransmitter release to cell cycle progression, apoptosis, secretion, and immune cell activation. Dysregulation of calcium ion transport is implicated in a spectrum of diseases, notably cardiovascular, neurodegenerative, metabolic, and muscular disorders. Numerous pharmacologic agents target these proteins, either by blocking channels (e.g., calcium channel blockers), modulating pumps or exchangers, or interfering with related signaling pathways. The broad biological importance and disease relevance of calcium transport proteins make them a diverse but essential class of therapeutic targets.

Other names

Calcium channelVoltage-gated calcium channel (VGCC)IP3 receptorRyanodine receptorStore-operated calcium channel (SOCC, e.g., ORAI1)Sodium-calcium exchanger (NCX)Sarco/endoplasmic reticulum Ca2+-ATPase (SERCA)Two-pore channel (TPC)Calcium ATPase

Inhibition of voltage-gated calcium influx (for blockers). Allosteric modulation or inhibition of ligand-gated or store-operated channels. Blocking or inhibition of Ca2+-ATPase activity. Modulation of antiport/symport ion exchange (e.g., sodium/calcium exchanger).